The arrival of Retatrutide ZPHC, at a strength of 120mg, is sparking considerable excitement within the healthcare community. This innovative dual GIP and GLP-1 receptor medication appears to provide significant improvements in fat reduction compared to existing therapies. Preliminary patient studies have demonstrated significant declines in body m